Abbott Laboratories (BSP:ABTT34) 3-Year EBITDA Growth Rate : 6.80% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Abbott Laboratories 3-Year EBITDA Growth Rate?

Abbott Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was R$0.65.

During the past 12 months, Abbott Laboratories's average EBITDA Per Share Growth Rate was -12.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 6.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 11.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Abbott Laboratories was 26.40% per year. The lowest was -34.00% per year. And the median was 11.00% per year.

Competitive Comparison of Abbott Laboratories's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Abbott Laboratories's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's 3-Year EBITDA Growth Rate falls into.

Abbott Laboratories 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Abbott Laboratories (BSP:ABTT34) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Abbott Laboratories 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (BSP:ABTT34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (BSP:ABTT34) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABT:Switzerland ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (BSP:ABTT34) Headlines

No Headlines